Aquestive Therapeutics, Inc. (AQST)
4.16
-0.07
(-1.65%)
USD |
NASDAQ |
May 22, 12:02
Aquestive Therapeutics Profit Margin (Quarterly) : -55.77% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -413.4% |
| Crinetics Pharmaceuticals, Inc. | -1.19K% |
| Harrow, Inc. | -62.44% |
| MariMed, Inc. | -9.54% |
| Journey Medical Corp. | -13.97% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -51.99% |
| Return on Invested Capital | -78.42% |
| Gross Profit Margin (Quarterly) | 75.99% |
| Operating Margin (Quarterly) | -29.10% |
| Return on Net Operating Assets | -284.3% |